Company intelligence / Profile preview

DNA-Invitrx

Guadalajara, Jalisco, Mexico

Ownership: Private
Development stage: Other

Overview

DNA-Invitrx is a biotechnology joint venture between California-based Invitrx Therapeutics and the DNA Corporation of Guadalajara, Mexico. Established in 2007, the company was formed to commercialize advanced regenerative medicine and tissue engineering products specifically for the Mexican market. Its primary focus includes the distribution and application of stem cell-based therapies and skin grafts for treating chronic wounds, burns, and diabetic ulcers. The company leverages proprietary adult stem cell and exosome technologies developed by Invitrx to provide solutions in aesthetics, ophthalmology, and reconstructive surgery.

Therapeutic areas: OtherEndocrinologyOphthalmologyDermatology
Modalities: Stem cell therapyCell therapyExosome-based therapyBiologic
Industry: Biotech

Partnerships

DNA Corporation of Guadalajara

Beyond the preview

Go deeper on DNA-Invitrx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-Invitrx.

Explore the full profile